太極集團(600129.SH):上半年淨利潤同比預減約71.90%
格隆匯7月14日丨太極集團(600129.SH)公佈2025年半年度業績預告,預計2025年半年度歸屬於上市公司股東的淨利潤約爲13,900萬元,同比降幅約71.90%。公司預計2025年半年度歸屬於上市公司股東的扣除非經常性損益的淨利潤約爲12,000萬元,同比降幅約74.47%。
受相關政策以及部分產品社會庫存持續消化等影響,2025年上半年公司胃腸感冒類、抗感染類、止咳類等主要產品銷售同比下降。面對業績及成本承壓,公司持續保持研發投入強度,加大產品二次開發和新產品研發力度;同時積極推進專業學術推廣體系建設,加強營銷改革轉型,強化運營管控,嚴格控制發貨,重點推進終端動銷。2025年上半年公司營業收入同比減少約21.60億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.